Business
Envoy Medical Appoints Chas McKhann to Board of Directors
Proven Med Tech Leader with an Established Track Record of Commercial Success and Optimizing Shareholder Value Leading to over $3.4 Billion in Successful ExitsWhite Bear Lake, Minnesota--(Newsfile Corp. - April 16, 2026) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company pioneering fully implanted hearing solutions, today announced the appointment of Chas McKhann, a seasoned medical technology executive with documented success, to its Board of Directors.Mr. McKhann
About this update from Boston Scientific Corporation
[{"type":"text","content":"Proven Med Tech Leader with an Established Track Record of Commercial Success and Optimizing Shareholder Value Leading to over $3.4 Billion in Successful Exits","length":159,"tagName":"p","attribs":{"class":"nfSubHeading"},"className":""},{"type":"text","content":"White Bear Lake, Minnesota--(Newsfile Corp. - April 16, 2026) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company pioneering fully implanted hearing solutions, today announced the appointment of Chas McKhann, a seasoned medical technology executive with documented success, to its Board of Directors.","length":345,"tagName":"p"},{"type":"text","content":"Mr. McKhann is a well-known and respected med tech leader with extensive experience creating and executing commercialization plans that have scaled into high-growth companies creating significant shareholder value. Most recently, he served as Chief Executive Officer of Silk Road Medical, which sold to Boston Scientific for $1.16 Billion, and Apollo Endosurgery, which also sold to Boston Scientific for approximately $615 million. Prior to those roles, Mr. McKhann served as the Chief Commercial Officer of Torax Medical and Intersect ENT prior to their acquisitors by Johnson and Johnson and Medtronic, respectively.","length":619,"tagName":"p"},{"type":"text","content":""We are extremely excited to welcome Chas to our Board," said Brent Lucas, CEO of Envoy Medical. "Chas brings a proven track record of commercial success and delivering strong outcomes for investors. We look forward to benefitting from his deep industry knowledge and experience to advance our mission of bringing our first-of-its-kind fully implanted cochlear implant to the millions of patients who are not treating their hearing loss. Adding his experience and perspective will further strengthen our strategic positioning and visibility."","length":562,"tagName":"p"},{"type":"text","content":"Mr. McKhann currently serves as Executive Chair of Distalmotion SA, an independent director at Exagen Inc., and is a Senior Advisor to McKinsey & Company. Mr. McKhann holds an MBA from the Stanford University Graduate School of Business and a BA in Political Science from Stanford University.","length":296,"tagName":"p"},{"type":"text","content":""I am thrilled to be joining the Envoy Medical team,&q...